Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma

Antibodies targeting the programmed cell death protein-1 (PD-1) molecule have been reported to hold promising antitumor activities in patients with nasopharyngeal carcinoma (NPC). However, only a small subset of NPC patients benefits from the anti-PD-1 monotherapy and factors that affect the treatme...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Liqin Xu, Yuxiang Ma, Chao Fang, Zhuobing Peng, Fangfang Gao, Janne Marie Moll, Shishang Qin, Qichao Yu, Yong Hou, Karsten Kristiansen, Wenfeng Fang, Susanne Brix, Li Zhang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-08-01
Edice:	Frontiers in Oncology
Témata:	NPC immunotherapy PD-1 TMB HLA EBV
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2022.953884/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!